SciSparc (SPRC) vs Alaunos Therapeutics (TCRT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SciSparc is the larger company by market cap ($2.6 million vs $2.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SPRC | TCRT |
|---|---|---|
| Share price | $4.43 | $0.781 |
| Market cap | $2.57M | $2.29M |
| 1-day change | -4.53% | -6.70% |
| P/E ratio (TTM) | 0.02 | — |
| EPS (TTM) | $248.24 | $-1.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $43.65 | $4.59 |
| 52-week low | $2.98 | $0.72 |
| Distance from 52-week high | -89.85% | -82.98% |
| Average volume | 180.20K | 796.09K |
| Shares outstanding | 580.97K | 2.93M |
| Employees | 3 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About SciSparc
SPRC stock →SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
Healthcare · Biotechnology · 3 employees
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Healthcare · Biotechnology · 1 employees
SPRC vs TCRT FAQ
Which is bigger, SciSparc or Alaunos Therapeutics?
SciSparc (SPRC) is larger, with a market capitalization of $2.57M compared with $2.29M for Alaunos Therapeutics (TCRT).
Are SciSparc and Alaunos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.